Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Proteomics International Laboratories Ltd. ( (AU:PIQ) ).
Proteomics International Laboratories Ltd has announced the application for the quotation of 1,351,352 fully paid ordinary securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions and is likely to enhance the company’s market presence by increasing its liquidity and potentially attracting more investors.
The most recent analyst rating on (AU:PIQ) stock is a Sell with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests and analytical services. The company is known for its work in proteomics, which involves the large-scale study of proteins, particularly their structures and functions.
Average Trading Volume: 147,943
Technical Sentiment Signal: Sell
Current Market Cap: A$56.73M
For a thorough assessment of PIQ stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue